| Ident. | Authors (with country if any) | Title |
|---|
| 000029 |
Vincent C. C. Cheng [République populaire de Chine] ; Kelvin K. W. To [République populaire de Chine, Hong Kong] ; Herman Tse [République populaire de Chine, Hong Kong] ; Ivan F. N. Hung [Hong Kong, République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine, Hong Kong] | Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? |
| 000048 |
Joseph H. W. Lee [Hong Kong] | Mixing of Multiple Buoyant Jets |
| 000088 |
A. Kaparianos [Grèce] ; E. Argyropoulou [Grèce] | Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome |
| 000229 |
J. P. Wong [Canada] ; M. E. Christopher [Canada] ; S. Viswanathan [Canada] ; X. Dai [Canada] ; A. M. Salazar [États-Unis] ; L.-Q. Sun [République populaire de Chine] ; M. Wang [République populaire de Chine] | Antiviral Role of Toll-Like Receptor-3 Agonists Against Seasonal and Avian Influenza Viruses |
| 000240 |
Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | The management of coronavirus infections with particular reference to SARS |
| 000269 |
Matthew Frieman [États-Unis] ; Ralph Baric [États-Unis] | Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation |
| 000278 |
Ian M. Mackay [Australie] | Human rhinoviruses : The cold wars resume |
| 000311 |
Arnaud Fontanet [France] | Les enseignements du SRAS |
| 000414 |
Francois Bricaire [France] ; Philippe Bossi [France] ; M. Pierre Pene ; M. Maurice Tubiana | Infections virales émergentes. Discussion : Les zoonoses, passé, présent et avenir |
| 000415 |
P. Hance [France] ; E. Garnotel [France] ; M. Morillon [France] | Chiroptères et zoonoses, une émergence sur les cinq continents |
| 000416 |
J. L. Heeney [Pays-Bas] | Zoonotic viral diseases and the frontier of early diagnosis, control and prevention |
| 000418 |
Yee-Joo Tan [Singapour] ; SENG GEE LIM [Singapour] ; WANJIN HONG [Singapour] | Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus |
| 000421 |
Bobby Pejcic [Australie] ; Roland De Marco [Australie] ; Gordon Parkinson [Australie] | The role of biosensors in the detection of emerging infectious diseases |
| 000423 |
Wai-Fu Ng [Hong Kong] ; Ka-Fai To [Hong Kong] ; William W. L. Lam [Hong Kong] ; Tak-Keung Ng [Hong Kong] ; Kam-Cheong Lee [Hong Kong] | The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1 : a review |
| 000439 |
LUHUA LAI [République populaire de Chine] ; XIAOFENG HAN [République populaire de Chine] ; HAO CHEN [République populaire de Chine] ; PING WEI [République populaire de Chine] ; CHANGKANG HUANG [République populaire de Chine] ; SHIYONG LIU [République populaire de Chine] ; KEQIANG FAN [République populaire de Chine] ; LU ZHOU [République populaire de Chine] ; ZHENMING LIU [République populaire de Chine] ; JIANFENG PEI [République populaire de Chine] ; YING LIU [République populaire de Chine] | Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase : SARS-CoV: A scénario of modern drug design |
| 000446 |
S. Schubert [Allemagne] ; J. Kurreck [Allemagne] | Oligonucleotide-based antiviral strategies |
| 000469 |
Lia Van Der Hoek [Pays-Bas] ; Krzysztof Pyrc [Pays-Bas] ; Ben Berkhout [Pays-Bas] | Human coronavirus NL63, a new respiratory virus |
| 000486 |
HAITAO YANG [République populaire de Chine] ; Mark Bartlam ; ZIHE RAO | Drug design targeting the main protease, the Achilles' heel of coronaviruses : SARS-CoV: A scénario of modern drug design |
| 000495 |
Bart L. Haagmans [Pays-Bas] ; Albert D. M. E. Osterhaus [Pays-Bas] | Coronaviruses and their therapy |
| 000500 |
PEI HAO [République populaire de Chine] ; MIN CHEN [République populaire de Chine] ; GUOQING ZHANG [République populaire de Chine] ; WEIZHONG HE [République populaire de Chine] ; YIXUE LI [République populaire de Chine] | Bioinformatics research on the SARS coronavirus (SARS_CoV) in China : SARS-CoV: A scénario of modern drug design |
| 000504 |
Yu-Shan Wu [Taïwan] ; Wen-Hsing Lin [Taïwan] ; John T.-A. Hsu [Taïwan] ; Hsing-Pang Flsieh [Taïwan] | Antiviral drug discovery against SARS-CoV |
| 000515 |
SHUAI CHEN [République populaire de Chine] ; HAIBIN LUO [République populaire de Chine] ; LILI CHEN [République populaire de Chine] ; JING CHEN [République populaire de Chine] ; JIANHUA SHEN [République populaire de Chine] ; WEILIANG ZHU [République populaire de Chine] ; KAIXIAN CHEN [République populaire de Chine] ; XU SHEN [République populaire de Chine] ; HUALIANG JIANG [République populaire de Chine] | An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins : Structures, functions and drug development : SARS-CoV: A scénario of modern drug design |
| 000559 |
Andreas J. Kesel [Allemagne] | Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS) |
| 000594 |
Henry Wilde [Thaïlande] ; Pakamatz Khawplod [Thaïlande] ; Thavatchai Khamoltham [Thaïlande] ; Thiravat Hemachudha [Thaïlande] ; Veera Tepsumethanon [Thaïlande] ; Boonlert Lumlerdacha [Thaïlande] ; Channarong Mitmoonpitak [Thaïlande] ; Visith Sitprija [Thaïlande] | Rabies control in South and Southeast Asia |
| 000604 |
John S. Oxford [Royaume-Uni] ; Shobana Balasingam [Royaume-Uni] ; Charlotte Chan [Royaume-Uni] ; Andrew Catchpole [Royaume-Uni] ; Robert Lambkin [Royaume-Uni] | New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus |
| 000679 |
Shiro Shigeta [Japon] ; Toshihiro Yamase [Japon] | Current status of anti-SARS agents |
| 000680 |
Susan R. Weiss [États-Unis] ; Sonia Navas-Martin [États-Unis] | Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus |
| 000735 |
C. Chastel [France] ; G. Charmot [France] | Epidémies bactériennes et virales d'origine zoonotique. rôle de la chasse et du dépeçage d'animaux sauvages |
| 000790 |
Mayuko Takeda-Shitaka [Japon] ; Daisuke Takaya [Japon] ; Chieko Chiba [Japon] ; Hirokazu Tanaka [Japon] ; Hideaki Umeyama [Japon] | Protein Structure Prediction in Structure based drug design : Protein structure prediction in medicinal chemistry |
| 000817 |
John Ziebuhr [Allemagne] | Molecular biology of severe acute respiratory syndrome coronavirus : Host-microbe interactions: viruses |
| 000894 |
L. J. Saif [États-Unis] | Animal coronavirus vaccines : Lessons for SARS |
| 000924 |
P. Bossi [France] ; A. Guihot [France] ; S. Ansart [France] ; F. Bricaire [France] | Actualités sur le syndrome respiratoire aigu sévère |
| 000925 |
Rustom Antia [États-Unis] ; Roland R. Regoes [États-Unis] ; Jacob C. Koella [France] ; Carl T. Bergstrom [États-Unis] | The role of evolution in the emergence of infectious diseases |
| 000933 |
D. A. Groneberg [Allemagne] ; L. Zhang [République populaire de Chine] ; T. Welte [Allemagne] ; P. Zabel [Allemagne] ; K. F. Chung [Royaume-Uni] | Severe acute respiratory syndrome: global initiatives for disease diagnosis |
| 000937 |
G. Bhaskar [Inde] ; Rakesh Lodha [Inde] ; S. K. Kabra [Inde] | Severe acute respiratory syndrome (SARS) |
